Osborn Williams & Donohoe’s iShares Biotechnology ETF IBB Stock Holding History

Osborn Williams & Donohoe’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-23,726	Closed	-$2.86M	–	277
2019 Q4	$2.86M	Sell	23,726 -7,440	-24%	-$830K	0.29%	91
2019 Q3	$3.1M	Sell	31,166 -238	-0.8%	-$24.9K	0.31%	90
2019 Q2	$3.43M	Buy	31,404 +6,006	+24%	+$639K	0.35%	82
2019 Q1	$2.84M	Buy	+25,398	New	+$2.79M	0.29%	93

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Osborn Williams & Donohoe's IBB Position: Q1 2020 in Review

Osborn Williams & Donohoe sold out of iShares Biotechnology ETF (IBB) in Q1 2020, closing a stake of 23,726 shares — an estimated $2.86M sold.

Osborn Williams & Donohoe first reported a position in IBB in Q1 2019 and held it in 4 quarters. The position peaked at $3.43M in Q2 2019. 668 funds tracked by Wall St. Rank hold IBB as of Q1 2020.

Osborn Williams & Donohoe reported no remaining iShares Biotechnology ETF position as of Q1 2020 after selling out during the quarter.
Osborn Williams & Donohoe sold 23,726 iShares Biotechnology ETF shares in Q1 2020, an estimated $2.86M.
Osborn Williams & Donohoe first reported a position in iShares Biotechnology ETF in Q1 2019 and held it in 4 quarters.
Osborn Williams & Donohoe's iShares Biotechnology ETF position peaked at $3.43M in Q2 2019.
668 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2020.

Based on Osborn Williams & Donohoe's 13F filing for Q1 2020, filed 4 May 2020.